The modifiability of neuronal response plasticity is called ''metaplasticity.'' In suppressing synaptic inhibition and facilitating induction of long-term excitatory synaptic plasticity, endocannabinoids (eCBs) act as agents of metaplasticity. We now report the discovery of a calcium-dependent mechanism that regulates eCB mobilization by metabotropic glutamate receptor (mGluR) activation. The switch-like mechanism primes cells to release eCBs and requires a transient rise in intracellular Ca 2؉ concentration ([Ca 2؉ ]i) but not concurrent activation of mGluRs. Conversely, short-term, [Ca 2؉ ]i-dependent eCB release can be persistently enhanced by mGluR activation. Hence, eCBs are also objects of metaplasticity, subject to higher levels of physiological control.
ndocannabinoids (eCBs) are important signaling molecules that modulate synaptic strength throughout the CNS (for reviews, see refs. 1-4). They control both short-and long-term forms of synaptic plasticity and are implicated in many animal behaviors. eCBs, which are fatty acid derivatives, are synthesized directly by enzymatic action on cellular plasma membrane phospholipids. Because they are not stored before use, eCBs are said to be available ''on-demand.'' Although the first identified eCB was anandamide, 2-arachidonyl glycerol (2-AG) is probably the principal ligand for cannabinoid receptors (CB1Rs) in much of the brain (5, 6). 2-AG synthesis is thought to proceed via phospholipase C (PLC) and the action of diacylglycerol lipase (DGL) on the PLC product, diacyglycerol (DAG). eCBs are retrograde messengers, and their release from postsynaptic cells may also be regulated. Physiological techniques cannot distinguish among synthesis, release, and transport processes, and we use the term ''mobilization'' to encompass all steps between stimulation of the eCB system and activation of CB1R. eCB mobilization occurs after either a rise in the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (7) (8) (9) or activation of G protein-coupled receptors (GPCRs), including dopaminergic (10, 11) , metabotropic glutamatergic (12, 13) , and muscarinic cholinergic (14) receptors.
In the hippocampus, CB1R is present in high concentrations on the synaptic terminals of certain GABAergic interneurons (15) . Ca 2ϩ -dependent eCB mobilization transiently suppresses CA1 pyramidal cell evoked inhibitory postsynaptic currents (eIPSCs) (7, 8) , a retrograde signal process called DSI (1) . Group I metabotropic glutamate receptor (mGluR) activation potently stimulates eCB mobilization, thereby depressing eIPSCs (12, 13) or excitatory postsynaptic currents (EPSCs) for short (seconds to minutes) or long (minutes to hours) (16, 17) periods of time, depending on the stimulation conditions.
Various stimuli use different biochemical pathways for eCB mobilization, which can be designated eCB mGluR , eCB mAChR , and eCB Ca . Pharmacological inhibitors of PLC abolish hippocampal long-term IPSC suppression (eCB-iLTD) initiated by group I mGluRs without affecting DSI (17, 18) . PLC ␤1 knockout mice lack both eCB mGluR and eCB mAChR , whereas DSI remains normal (19) . Hashimotodani et al. (19) showed that GPCR-triggered eCB mobilization had a dose-dependent reliance on [Ca 2ϩ ] i , and they proposed that PLC ␤1 is a ''coincidence detector'' through which a simultaneous rise in [Ca 2ϩ ] i and GPCR activation can initiate eCB mobilization. This model implies that the demand for eCBs is set by the degree of mGluR and [Ca 2ϩ ] i coactivation. Nevertheless, fundamental questions about the regulation of eCBs remain unanswered, and it is not clear whether a coincidence detector is the only control mechanism. We now report the discovery of a mode of regulation of eCB mGluR mobilization. We find that the mGluR-eCB pathway is subject to ''priming'' by a brief bolus rise in [Ca 2ϩ ] i , that is, an initially ineffective treatment with an mGluR agonist becomes effective in mobilizing eCBs after an influx of Ca 2ϩ . The relationship between Ca 2ϩ and mGluRs is reciprocal; i.e., prior activation of mGluRs enhances Ca 2ϩ -dependent eCB mobilization (eCB Ca ; i.e., DSI). Tests of the coincidence detection model revealed that it cannot account for priming. We conclude that there must be a higher level of control over eCB mGluR that will strongly influence eCB-dependent synaptic plasticity.
Results

Priming of mGluR-Mediated eCB Mobilization.
A simple on-demand model of eCB mobilization predicts that presentation of an appropriate stimulus will mobilize eCBs. However, if CA1 pyramidal cells had not first been tested for DSI, then the mGluR agonist dihydroxyphenylglycol (DHPG) did not elicit substantial eCB mGluR (i.e., eIPSC suppression Ն10%) in approximately half of the tested cells (39 of 77; e.g., Fig. 1a ). The DHPG concentration was either 10 M (n ϭ 16 cells) or 50 M (n ϭ 61 cells). We considered three explanations for this surprising result: the cells could not mobilize eCBs, the mGluR-coupled eCB pathways were inoperative, or the interneuron terminals lacked CB1Rs. To distinguish among them, we gave a DSI trial to pyramidal cells that had not generated eCB mGluR and found that DSI was readily induced (Fig. 1a) . This finding rules out two possibilities by showing that the pyramidal cells could mobilize eCBs and that CB1Rs were present. The deficiency appeared to be in the mGluR pathway.
The inability of high concentrations of mGluR agonists to trigger eCB mobilization has not been reported. In previous reports, cells were first tested for DSI before application of mGluR agonists, which was not done in the experiments of Fig.  1 . To determine whether a preceding DSI trial affected subsequent eCB mGluR responses, we tested two groups of cells that were essentially unresponsive to the initial DHPG application. After washout of DHPG, only one group received a single DSI trial before a second DHPG application. The DSI trial (e.g., Fig.  1 b and c) invariably enabled the second DHPG application to trigger larger eCB mGluR . Initially unresponsive cells that did not receive an intervening DSI trial remained unresponsive to a second application ( Fig. 1 a and c) . Hence, neither repeated DHPG applications nor the passage of time led to eCB mGluR enhancement. The DSI trial seemed to be responsible. We refer to the enhancing effect of the trial on eCB mGluR as priming. In the presence of the CB1R antagonist SR141716A, eIPSCs were depressed to 93.8 Ϯ 2.23% pre-''DSI trial'' (SR141716A blocked DSI) and to 99.1 Ϯ 4.46% afterward, n ϭ 6, indicating that the DHPG-induced suppression is an eCB-mediated process. Priming of eCB mGluR did not depend on a high concentration of DHPG because it occurred when 10 M DHPG was used [supporting information (SI) Fig. S1a ]. Thus, 50 M DHPG provides a stringent test for priming of eCB mGluR and was used unless otherwise noted.
There is a low level of CB1Rs on hippocampal glutamatergic terminals (20) , and eCBs slightly affect excitatory transmission (21 (13) , and eCB mGluR increases (19) . The binding of both Ca 2ϩ and the G protein products of mGluR to PLC ␤ increases its activity, thereby enabling it to detect the coincidence of the two stimuli. A key feature of the coincidence detector is the narrow time window over which it operates: in CA1 pyramidal cells PLC ␤1 only integrates the signals for Ϸ2 min after a 5-s depolarizing voltage step (19) . To test the hypothesis that the coincidence detection mechanism accounts for eCB mGluR priming, we measured the temporal window of the priming process by giving a DSI step after an ineffectual DHPG application and reapplying DHPG 3-23 min later (mean 11.5 Ϯ 2.74 min, n ϭ 7). The response to the second DHPG application was increased in every case ( Fig. 2 a- Although these results appeared incompatible with coincidence detection, the relevant Ca 2ϩ for DSI induction might not have been detected by bulk [Ca 2ϩ ] i measurements. Therefore, as another test, we included 35 mM 1,2-bis(2-aminophenoxy)-ethane-N,N,NЈ,NЈ-tetraacetate (BAPTA) in the whole-cell pipette and delivered a DSI step at various times after break-in. If given Ͻ3 min after break-in (mean 1.95 min; n ϭ 4), i.e., before internal equilibration of BAPTA, the DSI step primed eCB mGluR , even when DHPG was not bath-applied until 20 min later ( Fig.  2 d and f ) . During this long interval, BAPTA will have equilibrated in the cell and chelated excess Ca 2ϩ ; therefore, this result confirms that coincidence between a [Ca 2ϩ ] i rise and mGluR activation is not required for priming eCB mGluR . However, if the DSI step was given Ͼ6 min after break-in (mean 8.06 min, n ϭ 12), when there was higher and more uniform [BAPTA] in the cell, then neither DSI nor eCB mGluR could be elicited ( Fig. 2 e and f ). Hence, priming is Ca 2ϩ -dependent, but the primed state endures long after [Ca 2ϩ ] i has returned to baseline.
Priming Affects eCB Mobilization, Not Activation of CB1R. Priming could either enhance pyramidal cell generation of eCB mGluR or the responsiveness of the presynaptic CB1R. In the latter case, it would be impossible to activate CB1R in completely unprimed cells. To test this prediction, we again loaded cells with 35 mM BAPTA and did not stimulate them until Ͼ10 min after break-in to ensure that they remained unprimed. Neither DSI nor eCB mGluR could be elicited in these cells, confirming that they were loaded with BAPTA. However, the CB1R agonist CP 55,940 (1 M) suppressed eIPSCs in unprimed cells to the same extent as in primed cells ( Fig. 2 g and h) , indicating that priming does not up-regulate CB1R. We conclude that some step or sequence of steps in the eCB mobilization process is the target of the priming process. Accumulating evidence suggests that 2-AG, and not anandamide (AEA), is the active eCB in hippocampus; nevertheless, AEA could conceivably have a role in priming. The degradative enzyme for AEA, fatty-acid amide hydrolase (FAAH), can be inhibited by the FAAH inhibitor URB-597 (1 M) (22) to test for the influence of AEA. In cells treated with URB-597, DHPG initially suppressed eIPSC to 85.8 Ϯ 7.01% of baseline before a DSI trial, and to 50.1 Ϯ 10.7% afterward (P Ͻ 0.05, n ϭ 4, Fig.  S1b ). Priming evidently does not involve AEA.
eCB-iLTD Can Be Primed. CB1R-dependent iLTD induction (17) requires mGluR activation lasting Ϸ10 min, or high-frequency synaptic stimulation (HFS), suggesting that different mechanisms are involved in iLTD than in transient eCB mGluR mobilization. In naïve cells that were unresponsive to a 10-min DHPG application, a DSI priming step enabled a second DHPG exposure to elicit prominent eCB mGluR and eCB-iLTD (Fig. 3 a and  b) . Without a prior DSI trial, a second DHPG application remained ineffective (n ϭ 7). We also found that synaptic HFS had only slight and transient suppressive effects on eIPSCs in naïve cells, whereas after priming, HFS produced robust iLTD ( Fig. 3 c and d) . The eCB transporter inhibitor VDM-11 prevents exogenous eCBs loaded into cells from exiting them, and it prevents induction of mGluR-dependent iLTD (23) . To determine whether the transport process might be the target of priming, we loaded pyramidal cells with 10 M VDM-11, but we found that priming of DHPG responses could still be elicited (Fig. 3 e and  f ) . Intracellular VDM-11 prevented the induction of hippocampal HFS-iLTD (e.g., Fig. 3e ; group data in Fig. 3d ), confirming the efficacy of VDM-11. The experiments of Fig. 2 (17, 18) . However, we found that neither intranor extracellular application of U73122 inhibited eCB mGluR and that the DGL inhibitor RHC 80267 (60 M) did not block eCB mGluR (18) . To try to ensure that the cells had not been primed before these tests, we incubated slices for Ͼ1 h before and after transferring them to the recording chamber with 6 M U73122 or 60 M RHC 80267, and we included the drugs in the patch pipette as well. Nevertheless, these treatments did not prevent priming (Fig. S2) . RHC 80267 is a comparatively weak DGL inhibitor in biochemical assays whereas tetrahydrolipstatin, tetrahydrolipstatin (THL; orlistat), is more potent (24) , and it inhibits some eCB responses (18, (25) (26) (27) . We found that extracellular application of 10 M THL reduced DSI and virtually abolished the carbachol (CCh)-induced eCB mAChR response without preventing eCB mGluR priming (Fig. 4 a and c) . Interestingly, internal THL, also 10 M, blocked eCB mAChR but not DSI or eCB mGluR ; Fig.  4 b and c and previous evidence (18) suggest that the three eCB pathways are not identical. Because THL antagonizes lipase activities downstream of Ca 2ϩ (24) , these experiments are compatible with the concept that a rise in [Ca 2ϩ ] i primes cells independently of DGL. Moreover, the priming mechanism appears to be distinct from the Ca 2ϩ -dependent and eCB mAChR pathways.
eCBmAChR Does Not Require Priming. Priming could still involve steps upstream of PLC and DGL that are common to both eCB mGluR and eCB mAChR . In this case, the eCB mAChR responses would also require priming. We tested the eCB mAChR responses with the same protocol that was used for priming of the eCB mGluR pathway: a 1-min application of 0.2 M CCh followed by a single DSI trial and a second application of CCh. The eIPSCs were suppressed to 83.5 Ϯ 1.85% of control before DSI and to 74.6 Ϯ 7.05% of control afterward (NS, P Ͼ 0.2, paired t test, n ϭ 6, data not shown). Hence, eCB mAChR was not subject to priming.
Priming of DSI by mGluR. If priming represents a specific interaction between Ca 2ϩ and the eCB mGluR pathways, then they might interact reciprocally in the priming process. This model predicts that prior mGluR activation would persistently potentiate DSI.
To test this idea, we administered three DSI trials in cells (n ϭ 10) and then bath-applied 50 M DHPG for Ͻ5 min to avoid inducing iLTD. We adjusted the voltage step to produce moderate DSI (Յ40 reduction in eIPSC) so that an enhancement could be detected. DHPG was then washed out of the bath, while the mGluR antagonists, LY367385 (100 M) and 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) (10 M) were applied to halt the action of DHPG. DSI was evoked every 1.5 min throughout. Within 10 min of the start of DHPG washout, the eIPSCs had recovered to control levels; however, we continued washing for 10 more min. At this point, DSI was still significantly increased ( Fig. 5 a and b) . Control DSI reduced eIPSCs to 74.0 Ϯ 2.21% of baseline, whereas post-DHPG DSI reduced them to 60.5 Ϯ 1.98% of baseline (P Ͻ 0.001; paired t test, n ϭ 9). Hence, there could be a reciprocal relationship between the eCB mGluR and eCB Ca pathways via the priming pathway. Another prediction is that eCB mAChR , which does not require priming, would not cause lasting enhancement of DSI. Indeed, the effects of a 4-min application of 1 M CCh, which strongly suppressed eIPSCs and enhanced DSI, were completely reversed when CCh was washed from the chamber (and the mAChR antagonist, atropine, 1 M, was added; Fig. 5c ). Control DSI reduced the mean eIPSCs to 72.0 Ϯ 3.56% of baseline; post-CCh DSI reduced eIPSCs to 73.9 Ϯ 3.86% of baseline (NS, P Ͼ 0.5, paired t test, n ϭ 7).
Discussion
This article reports a powerful mechanism for regulating eCB mobilization. We show that eCB mGluR was controlled by a Ca 2ϩ -dependent priming process that was turned on quickly and remained active for long periods. Sensitivity to pharmacological antagonists and intracellular Ca 2ϩ chelators, as well as timing requirements, distinguished the priming mechanism from the usual model of 2-AG synthesis and release (6) and from the PLC coincidence detection mechanism (19) . Priming was not caused by up-regulation of CB1R; rather, it affected the coupling between mGluR activation and eCB mobilization. Both shortterm and long-term eCB mGluR responses could be primed. Primed cells were more susceptible to iLTD induction by physiological stimuli and are therefore more likely to undergo long-term potentiation (LTP) (17) . We also demonstrated a LTP of DSI caused by prior mGluR, but not mAChR, activation. By suppressing IPSP/Cs, DSI can facilitate LTP expression (28) . Thus, DSI potentiation is another means by which endocannabinoids can take part in metaplasticity. A recent report (29) shows potentiation of DSI by low-frequency field potential stimulation, perhaps representing synaptic activation of the same mGluR-dependent priming mechanism. Unlike priming, febrile seizures (30) or tetanic stimulation (31) potentiate DSI by up-regulation of CB1Rs, thus underscoring the varieties of endocannabinoid plasticity.
Our observations do not contradict previous studies of eCB mGluR . It has been conventional to test for DSI (or DSE) before any other manipulations (e.g., 7, 13, 17, 19) to reduce time lost on unresponsive cells. We suggest that these initial tests may have primed the cells. Cells that respond with eCB mGluR without explicit experimental priming might have been preprimed naturally, or they may have been inadvertently primed (e.g., from Ca 2ϩ influx during break-in). Indeed, it is critical that establishment of whole-cell recording be done as gently as possible; cells that undergo instabilities during break-in or those requiring high holding currents are usually found to be primed. The results are not incompatible with the coincidence detection model, although they raise questions about its role. The model emerged from work on tissue-cultured cells from wildtype and PLC ␤1 knockout animals; thus, developmental changes may reduce direct dependence of the eCB system on PLC ␤ in slices. Alternatively, PLC ␤ could be upstream of the eCB signaling process, such that its constitutive elimination removes essential substrates of eCB signaling. Hashimotodani et al. (19) found that U73122 thoroughly blocked PLC ␤1 as measured by a TRPC6 assay, but side effects confounded their tests of U73122 on eCB mGluR . U73122 does not have adverse effects in slices, and we find that the PLC ␤ antagonist does not inhibit eCB priming or mobilization (see also refs. 17 and 18).
Resolution of these complex issues will require a full understanding of the biochemical pathways of eCB synthesis, and differences may exist among preparations and brain regions. U73122 blocks 2-AG synthesis in hippocampal and corticostriatal cells (32) . In the cerebellum, PLC ␤4 is essential for eCB mGluR signaling (26) , and U73122 may reduce DSI (33) , although this latter possibility is disputed (34) . In the neocortex, extracellular U73122 reduces stimulation-induced eCB-LTD (35), but U73122 is ineffective in ventral tegmental area (VTA) (25) . Ca 2ϩ and mGluRs may interact through other mechanisms besides PLC ␤ to facilitate eCB mobilization, although complex effects of U73122 (36) preclude firm conclusions based on its use. Intracellular DGL inhibition blocks stimulus train-induced DSE in VTA and cerebellum (27) , and a DGL inhibitor reduces DSE in autaptic hippocampal cultures (37) . Interestingly, extracellular application of neither RHC 80627 nor THL reduced cerebellar DSE (27) . DGL ␣ is found in synaptic spines apposed to glutamate terminals but is not near GABA terminals (38) . The insensitivity of eCB-dependent EPSC suppression to priming may reflect these or other distinctions between the synapses. Finally, our results suggest that the interpretation of ondemand when applied to eCB mobilization can be modified. Mobilization of eCBs is sensitive to prior neuronal activity. The requirement for a cell to have experienced a significant transient increase in [Ca 2ϩ ] i before it can mount a robust eCB mGluR response constrains the eCB system. In effect, priming represents a hebbian condition requiring both postsynaptic (rise in [Ca 2ϩ ] i ) and presynaptic (release of glutamate) factors for the mobilization of eCB mGluR . Behaviorally, priming would seem to be ideally suited for an attentional function that sets the stage for subsequent eCB-assisted, associational learning processes. The growing number of eCB-mediated functions in physiological and pathophysiological phenomena makes understanding the mechanisms of eCB metaplasticity (39) an important challenge.
Materials and Methods
Animal handling procedures were approved by the University of Maryland School of Medicine IACUC. Conventional hippocampal slices were used. Male rats, 5-7 weeks old, were heavily sedated with isoflurane and decapitated. Slices, 400 m thick, were cut on a Vibratome (Tech Products) in an ice-cold bath solution and then stored at room temperature for Ͼ1 h before transfer to the recording chamber (40) . The extracellular recording solution contained 120 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 2 mM MgSO4, 1 mM NaH2PO4, 25 mM NaHCO3, and 20 mM glucose, and it was bubbled with 95% O2, 5% CO2 (pH 7.4) at 30°C. Ionotropic glutamate responses were blocked with either 2 mM kynurenic acid or 50 M AP-5 plus 10 M NBQX. Whole-cell pipettes contained 90 mM CsCH 3SO3, 10 mM Hepes, 0.2 mM BAPTA, 0.3 mM Tris-GTP, 4 mM Mg-ATP, 50 mM CsCl, 1 mM MgCl2, and 5 mM QX-314 (pH 7.25). An Axopatch 1C and pClamp 8.0 (Axon Instruments) were used. Extracellular stimulation (100-s pulses at 0.25 Hz) were delivered in stratum radiatum because doing so induces large, eCB-sensitive eIPSCs, (e.g., 1), and most of the CCK-and CB1R-expressing interneurons are in this region (3). Cells were voltageclamped at Ϫ70 mV, and DSI was induced by a 1-or 2-s voltage step to 0 mV. Electrode resistances in the bath were 3-6 M⍀. Statistical tests among groups were done with ANOVA followed by Holm-Sidak post hoc tests (SigmaStat). Paired t tests were used for single comparisons, except as noted. The significance level for all tests was P Ͻ 0.05 ( * ). Group means Ϯ SEMs are shown for display purposes.
